Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Synshjelpemidler AS
AS
Active
Org 996868656
Sporveisgata 10, 4. Etasje, 0354
Oslo
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2011 · 15 years old
8 employees
Monitor
Share
Norway
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Synshjelpemidler AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
41M
31M
21M
10M
0M
2021: 28M
28M
2021
2022: 29M (+4% vs 2021)
29M
+4%
2022
2023: 29M (0% vs 2022)
29M
0%
2023
2024: 30M (+3% vs 2023)
30M
+3%
2024
2025: 33M (+10% vs 2024)
33M
+10%
2025
EBITDA
NOK millions
2M
2M
1M
1M
0M
2021: 2M
2M
2021
2022: 1M (-50% vs 2021)
1M
-50%
2022
2023: 0M (-100% vs 2022)
0M
-100%
2023
2024: 1M
1M
2024
2025: 2M (+100% vs 2024)
2M
+100%
2025
Income statement
NOK thousands
Item
2025
2024
2023
2022
2021
Revenue
32 514
30 444
29 383
29 485
27 634
Staff expenses
−5 720
−5 129
−5 283
−5 541
−5 496
EBITDA
2 067
1 304
251
1 078
2 372
Depreciation & amort.
−5
−33
−47
−53
−68
EBIT
2 062
1 271
204
1 025
2 304
Net financials
196
121
48
−40
−11
Profit before tax
2 257
1 392
252
985
2 293
Tax
497
307
57
217
504
Net profit
1 760
1 086
196
768
1 788
Balance sheet
NOK thousands
Item
2025
2024
2023
2022
2021
Total assets
17 898
15 381
14 904
14 363
12 953
Equity
14 043
12 284
11 198
11 002
10 234
Long-term debt
0
0
0
0
0
Short-term debt
3 855
3 097
3 706
3 361
2 719
Total debt
3 855
3 097
3 706
3 361
2 719
Financial ratios
5-year trend
EBITDA margin
6,4 %
This company
15,8 %
Market median
This company
Market median
59% below market
2021
2025
Equity ratio
78,5 %
This company
38,2 %
Market median
This company
Market median
105% above market
2021
2025
Return on equity
12,5 %
This company
18,4 %
Market median
This company
Market median
32% below market
2021
2025
Net profit margin
5,4 %
This company
8,1 %
Market median
This company
Market median
33% below market
2021
2025
Asset turnover
1,82×
This company
1,12×
Market median
This company
Market median
62% above market
2021
2025
Debt / equity
0,27×
This company
0,62×
Market median
This company
Market median
56% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
More on Synshjelpemidler AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
